Marchex CFO granted 56,089 restricted stock units

Nagle Brian reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

Form Type

Rhea-AI Filing Summary

Nagle Brian reported acquisition or exercise transactions in this Form 4 filing.

Marchex Inc Chief Financial Officer receives new equity award. Brian Nagle was granted 56,089 restricted stock units effective February 17, 2026. The award was recorded at a price of $0.00 per unit, reflecting a non-cash grant.

Each restricted stock unit represents the right to receive one share of Marchex Class B common stock upon vesting. The units vest in full on the first anniversary of the grant date, meaning all 56,089 units are scheduled to vest one year after February 17, 2026, if conditions are met.

Insider Trade Summary

Grant/Award: 56,089 shares

Grant/Award 1 txn

Insider Nagle Brian

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	56,089	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 56,089 contracts (Direct)

Footnotes (1)

F1. Restricted stock units award effective February 17, 2026 (the "Grant Date"). Each restricted stock unit represents the right to receive one share of the Corporation's Class B Common Stock upon vesting, which occurs in full on the first anniversary of the Grant Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marchex (MCHX) report for Brian Nagle?

Marchex reported that CFO Brian Nagle received a grant of 56,089 restricted stock units. This is a non-cash equity award recorded at $0.00 per unit, tied to future vesting in Marchex Class B common stock.

How many restricted stock units were granted to the Marchex (MCHX) CFO?

Brian Nagle was granted 56,089 restricted stock units. These units give him the right to receive an equal number of Marchex Class B common shares once they vest, aligning his compensation with the company’s future share performance.

When do Brian Nagle’s Marchex (MCHX) RSUs vest?

The restricted stock units granted to Brian Nagle vest in full on the first anniversary of February 17, 2026. On that date, subject to conditions, each unit converts into one share of Marchex Class B common stock.

Is the Marchex (MCHX) CFO’s RSU grant an open-market stock purchase?

No, the transaction is an equity award, not an open-market purchase. The Form 4 shows a grant of 56,089 restricted stock units at $0.00 per unit, classified as a grant or award acquisition rather than a buy on the stock market.

What type of security was granted to the Marchex (MCHX) CFO?

The security granted is restricted stock units, each representing the right to receive one share of Marchex Class B common stock upon vesting. This structure links executive compensation to the company’s future share value after the vesting date.

How many Marchex (MCHX) RSUs does the CFO hold after this grant?

After this grant, Brian Nagle directly holds 56,089 restricted stock units. This figure reflects his total RSU holdings following the award effective February 17, 2026, as reported in the Form 4 insider filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/18/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nagle Brian

(Last)

(First)

(Middle)

1200 5TH AVE

SUITE 1300

(Street)

SEATTLE

98101

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MARCHEX INC [ MCHX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	02/17/2026		A		56,089		⁽¹⁾	⁽¹⁾	Class B Common Stock	56,089	$0	56,089	D

Explanation of Responses:

1. Restricted stock units award effective February 17, 2026 (the "Grant Date"). Each restricted stock unit represents the right to receive one share of the Corporation's Class B Common Stock upon vesting, which occurs in full on the first anniversary of the Grant Date.

	/s/ Brian Nagle	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR